Evidence map›Paper›PMID 26491309›Full record

ArticleInternational journal of nanomedicine2015

Antibacterial activity of neem nanoemulsion and its toxicity assessment on human lymphocytes in vitro.

Jayakumar Jerobin, Pooja Makwana, R S Suresh Kumar, Rajiv Sundaramoorthy, Amitava Mukherjee, Natarajan Chandrasekaran

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Nanoscale advances · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Underutilized PlantRussian agricultural sciences · 2023
    Article
  7. Review
  8. Article
  9. Exploring the therapeutic potential of Neem (Annals of translational medicine · 2022
    Review
  10. Low-energy assisted sodium alginate stabilizedBiotechnology reports (Amsterdam, Netherlands) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jayakumar JerobinCentre for Nanobiotechnology, VIT University, Vellore, Tamil Nadu, India.
Pooja MakwanaCentre for Nanobiotechnology, VIT University, Vellore, Tamil Nadu, India.
R S Suresh KumarCentre for Nanobiotechnology, VIT University, Vellore, Tamil Nadu, India.
Rajiv SundaramoorthyCentre for Nanobiotechnology, VIT University, Vellore, Tamil Nadu, India.
Amitava MukherjeeCentre for Nanobiotechnology, VIT University, Vellore, Tamil Nadu, India.
Natarajan ChandrasekaranCentre for Nanobiotechnology, VIT University, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neem (Azadirachta indica) is recognized as a medicinal plant well known for its antibacterial, antimalarial, antiviral, and antifungal properties. Neem nanoemulsion (NE) (O/W) is formulated using neem oil, Tween 20, and water by high-energy ultrasonication. The formulated neem NE showed antibacterial activity against the bacterial pathogen Vibrio vulnificus by disrupting the integrity of the bacterial cell membrane. Despite the use of neem NE in various biomedical applications, the toxicity studies on human cells are still lacking. The neem NE showed a decrease in cellular viability in human lymphocytes after 24 hours of exposure. The neem NE at lower concentration (0.7-1 mg/mL) is found to be nontoxic while it is toxic at higher concentrations (1.2-2 mg/mL). The oxidative stress induced by the neem NE is evidenced by the depletion of catalase, SOD, and GSH levels in human lymphocytes. Neem NE showed a significant increase in DNA damage when compared to control in human lymphocytes (P<0.05). The NE is an effective antibacterial agent against the bacterial pathogen V. vulnificus, and it was found to be nontoxic at lower concentrations to human lymphocytes.

Indexed as

AdultAnti-Bacterial AgentsAzadirachtaCell DeathCell MembraneCell SurvivalComet AssayDNA DamageEmulsionsHumansLymphocytesMaleNanoparticlesOxidative StressParticle SizeToxicity TestsAnti-Bacterial AgentsEmulsionsantibacterialcytotoxicitygenotoxicitylymphocytesnanoemulsionneem

Identifiers

PMID26491309
PMCPMC4599620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.